This federal contract award, with an ID of SPE2DB22D1017|SPE2DB25FF1BH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,234.71 delivery order contract is for the supply of 4566692178 LISDEXAMFETAMINE 50 MG CAPSULE 100S, with a period of performance through December 12, 2024.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
The contract award reviewed does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive experience in providing pharmaceutical and medical products to federal agencies, particularly the DLA, positions the company as a key vendor for supporting the healthcare needs of the U.S. military and veterans' healthcare systems.
Generated 3/12/25, 9:51 AM